Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2012
05/23/2012CN101475942B B19 virus VP1 unique region gene
05/23/2012CN101474382B Medicine for treating three major diseases of grass carp
05/23/2012CN101412984B Streptococcus suis type 2 three-component subunit vaccine and use
05/23/2012CN101406698B Dog type II adenovirus live vector recombinant vaccine for displaying protective antigen of rabies virus
05/23/2012CN101376891B Preparation of novel tuberculosis vaccine and use thereof
05/23/2012CN101376025B Bacillus tubercle gene vaccine for treating medicine-tolerant pulmonary tuberculosis
05/23/2012CN101367750B (1S,2S,3S,4R)-3-[(1S)-1-acet-ammonia-2-ethyl-butyl]-4- guanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid aqua compound and medical uses thereof
05/23/2012CN101353668B Mouse beta-alexin 1 recombinant plasmids, polypeptides, uses and preparations thereof
05/23/2012CN101343327B Antiviral protein and uses thereof
05/23/2012CN101342239B Pure natural medicament for treating AIDS
05/23/2012CN101328123B 5-oxo-substituted benzene acryloyl quinate methyl ester compound and use thereof
05/23/2012CN101323635B Panax notoginseng saponins ST-4, and medicinal composition, preparation and use thereof
05/23/2012CN101264258B Medicaments for preventing and controlling infectious diseases in genital tract of male and female
05/23/2012CN101252928B Quinoline derivatives as antibacterial agents
05/23/2012CN101240019B Enterorrhagia colibacillus 0157:H7 Shiga toxin 2A1 subunit active segment Stx2a1 recombination protein, expression method and application
05/23/2012CN101235083B HIV-I resisting polypeptide, coded sequence and use thereof
05/23/2012CN101138566B Prevention and treatment process for infectious diseases and other diseases by using immunity effect compounds
05/23/2012CN101119978B HSP90-inhibiting triazole derivatives
05/23/2012CN101084991B Tibetan medicine tangut dragonhead extraction and its application in preparing antivirus medicine
05/23/2012CN101066311B Total jasminoidin extract and its preparation process
05/23/2012CN101053600B Medicinal composition for treating cough and preparation method and application thereof
05/23/2012CN101023077B Method for manufacturing enantiomeric imidazole compounds
05/22/2012US8183362 Method and medicament for inhibiting the expression of a given gene
05/22/2012US8183361 Oligonucleotide-containing pharmacological compositions and their use
05/22/2012US8183352 Attenuated vif DNA immunization cassettes for genetic vaccines
05/22/2012US8183273 Bicyclic compound, production and use thereof
05/22/2012US8183215 Method of administering oral flora-improving agent, antibacterial agent and growth promoter
05/22/2012US8183208 Targeted delivery of drugs for the treatment of viral infections
05/22/2012US8183009 Assaying cellular markers for the evaluation of tumors
05/22/2012US8182996 Compositions and methods for detecting Klebsiella pneumoniae
05/22/2012US8182820 Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens
05/22/2012CA2716268C Composition and method for irrigation of a prepared dental root canal
05/22/2012CA2660355C Polynucleotide vaccine formulation against pathologies of the horse
05/22/2012CA2656415C Novel pyridazine compound and use thereof
05/22/2012CA2504317C Sustained release of antiinfectives
05/22/2012CA2492832C Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
05/22/2012CA2491296C Methods for treating psychosis associated with interferon-.alpha. therapy
05/22/2012CA2436107C Kyberdrug as autovaccines with immune-regulating effects
05/18/2012WO2012065121A2 Metabolized conditioned growth medium and methods of use
05/18/2012WO2012065055A2 Fusion proteins for hiv therapy
05/18/2012WO2012064991A1 Antisense antibacterial compounds and methods
05/18/2012WO2012064654A1 Methods for prevention and treatment of influenza
05/18/2012WO2012064601A1 Methods of treating and preventing rhinovirus infection
05/18/2012WO2012062996A1 Derivatives of 6-amino-6-deoxyglucosamine and use of same as antibacterial agents
05/18/2012WO2012062951A1 Novel duganella strains isolated from rhizosphere of wild and cultivated olive trees and use thereof in the production of violacein
05/18/2012WO2012062906A1 Peptides as bioactive compounds
05/18/2012WO2012062870A1 Uracyl spirooxetane nucleoside phosphoramidates
05/18/2012WO2012062869A1 Uracyl spirooxetane nucleoside phosphoramidates
05/18/2012WO2012062847A1 Use of 2',5'-oligoadenylate derivative compounds
05/18/2012WO2012062691A1 Pharmaceutical compositions for treating hcv infections
05/18/2012WO2012062685A2 Pharmaceutical composition for treating hcv infections
05/18/2012WO2012062218A1 Soluble pd-1 variants, fusion constructs, and uses thereof
05/18/2012WO2012062214A1 Caspofungin analog, and preparation method and applications thereof
05/18/2012WO2012062213A1 Caspofungin analog and applications thereof
05/18/2012WO2012061920A1 Topical organic acid salt compositions suitable for treating infections
05/18/2012WO2012038979A3 A process for preparation of ertapenem
05/18/2012WO2012003320A3 Flavivirus host-range mutations and uses thereof
05/18/2012WO2011156674A3 Thioether prodrug compositions as anti-hiv and anti-retroviral agents
05/18/2012WO2011110930A3 Rifaximin ready-to-use suspension
05/18/2012CA2834381A1 Topical organic acid salt compositions suitable for treating infections
05/18/2012CA2817418A1 Highly immunogenic hiv p24 sequences
05/18/2012CA2817090A1 Antisense antibacterial compounds and methods
05/18/2012CA2816554A1 Use of 2',5'-oligoadenylate derivative compounds
05/18/2012CA2812665A1 Pharmaceutical composition for treating hcv infections
05/17/2012US20120124683 Delivery method
05/17/2012US20120123365 Absorbent Article with Philic Anhydrous Lotion
05/17/2012US20120123093 Novel surface antigen
05/17/2012US20120122982 Use of pufas to treat nerve damage
05/17/2012US20120122962 Modified Small Interfering RNA Molecules and Methods of Use
05/17/2012US20120122939 Alkylsulfonyl-substituted thiazolide compounds
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122918 Antibacterial agents
05/17/2012US20120122917 Method For Treatment Of HIV And Diseases Of Immune Dysregulation
05/17/2012US20120122902 Pyrimidine derivative, preparation method and use thereof
05/17/2012US20120122896 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122887 Solid state forms of a potent hcv inhibitor
05/17/2012US20120122882 Substituted Pyrrolo-Pyrimidine Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors
05/17/2012US20120122880 Thioxanthene derivatives for the treatment of infectious diseases
05/17/2012US20120122879 Compounds useful as protein kinase inhibitors
05/17/2012US20120122877 Compositions for Treating Bacterial Infections
05/17/2012US20120122872 Treatment or Prevention of Fungal Infections with PDK1 Inhibitors
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122864 Inhibitors of hcv ns5a
05/17/2012US20120122852 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122839 Novel pyrrolidin-2-ones
05/17/2012US20120122833 Deuterium-enriched meropenem
05/17/2012US20120122831 Method and device for rapid detection of bacterial antibiotic resistance/susceptibility
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
05/17/2012US20120122819 Guanine riboswitch binding compounds and their use as antibiotics
05/17/2012US20120122818 Lung-targeted drugs
05/17/2012US20120122817 Heterocyclic urea derivatives and methods of use thereof
05/17/2012US20120122811 Bicyclic nucleosides and nucleotides as therapeutic agents
05/17/2012US20120122809 Antibacterial aminoglycoside analogs
05/17/2012US20120122808 Macrolide synthesis process and solid-state forms
05/17/2012US20120122804 Substituted quinobenzoxazine analogs
05/17/2012US20120122769 Antisense antibacterial compounds and methods
1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 1798